Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult Participants
Clinical trial NCT04492020 · COMPLETED
Trial details
- NCT number
- NCT04492020
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-21
- Primary completion
- 2022-04-19
- Enrollment
- 518
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.